These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 20001756

  • 1. Efficacy and safety of dronedarone: a review of randomized trials.
    Christiansen CB, Torp-Pedersen C, Køber L.
    Expert Opin Drug Saf; 2010 Jan; 9(1):189-99. PubMed ID: 20001756
    [Abstract] [Full Text] [Related]

  • 2. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH, ATHENA Investigators.
    Am J Cardiol; 2011 Apr 01; 107(7):1019-22. PubMed ID: 21296333
    [Abstract] [Full Text] [Related]

  • 3. Dronedarone: current evidence and future questions.
    Schafer JA, Kjesbo NK, Gleason PP.
    Cardiovasc Ther; 2010 Apr 01; 28(1):38-47. PubMed ID: 20074258
    [Abstract] [Full Text] [Related]

  • 4. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ, Schmitt J, Hohnloser SH.
    J Cardiovasc Pharmacol Ther; 2010 Dec 01; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [Abstract] [Full Text] [Related]

  • 5. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV, Wolbrette DL, Samii S, Banchs JE, Penny-Peterson E, Gonzalez MD.
    J Cardiovasc Pharmacol Ther; 2010 Dec 01; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [Abstract] [Full Text] [Related]

  • 6. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT, Ehrlich JR, Hohnloser SH.
    J Cardiovasc Electrophysiol; 2006 Sep 01; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
    Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF.
    J Am Coll Cardiol; 2009 Sep 15; 54(12):1089-95. PubMed ID: 19744618
    [Abstract] [Full Text] [Related]

  • 8. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ, Crijns HJ, Torp-Pedersen C, van Eickels M, Gaudin C, Page RL, Hohnloser SH, ATHENA Investigators.
    Circulation; 2009 Sep 29; 120(13):1174-80. PubMed ID: 19752319
    [Abstract] [Full Text] [Related]

  • 9. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D, Cheng-Lai A.
    Cardiol Rev; 2009 Sep 29; 17(5):230-4. PubMed ID: 19690474
    [Abstract] [Full Text] [Related]

  • 10. Impact of dronedarone in atrial fibrillation and flutter on stroke reduction.
    Christiansen CB, Torp-Pedersen C, Køber L.
    Clin Interv Aging; 2010 Apr 07; 5():63-9. PubMed ID: 20396635
    [Abstract] [Full Text] [Related]

  • 11. Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
    Hohnloser SH, Connolly SJ, Crijns HJ, Page RL, Seiz W, Torp-Petersen C.
    J Cardiovasc Electrophysiol; 2008 Jan 07; 19(1):69-73. PubMed ID: 18031520
    [Abstract] [Full Text] [Related]

  • 12. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN, Connolly SJ, Crijns HJ, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH, EURIDIS and ADONIS Investigators.
    N Engl J Med; 2007 Sep 06; 357(10):987-99. PubMed ID: 17804843
    [Abstract] [Full Text] [Related]

  • 13. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B, Lip GY.
    Expert Opin Pharmacother; 2010 Dec 06; 11(17):2775-8. PubMed ID: 21050033
    [Abstract] [Full Text] [Related]

  • 14. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA, Salvetti M.
    Ther Adv Cardiovasc Dis; 2010 Jun 06; 4(3):155-64. PubMed ID: 20418270
    [Abstract] [Full Text] [Related]

  • 15. Drug safety evaluation of dronedarone in atrial fibrillation.
    De Ferrari GM, Dusi V.
    Expert Opin Drug Saf; 2012 Nov 06; 11(6):1023-45. PubMed ID: 22971242
    [Abstract] [Full Text] [Related]

  • 16. Dronedarone.
    Patel C, Yan GX, Kowey PR.
    Circulation; 2009 Aug 18; 120(7):636-44. PubMed ID: 19687370
    [Abstract] [Full Text] [Related]

  • 17. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I.
    Cardiovasc Drugs Ther; 2009 Oct 18; 23(5):385-93. PubMed ID: 19669399
    [Abstract] [Full Text] [Related]

  • 18. Meta-analysis of cardiovascular outcomes with dronedarone in patients with atrial fibrillation or heart failure.
    Chatterjee S, Ghosh J, Lichstein E, Aikat S, Mukherjee D.
    Am J Cardiol; 2012 Aug 15; 110(4):607-13. PubMed ID: 22608952
    [Abstract] [Full Text] [Related]

  • 19. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
    Dale KM, White CM.
    Ann Pharmacother; 2007 Apr 15; 41(4):599-605. PubMed ID: 17389667
    [Abstract] [Full Text] [Related]

  • 20. Dronedarone. atrial fibrillation: too many questions about long-term adverse effects.
    Prescrire Int; 2010 Aug 15; 19(108):149-52. PubMed ID: 20939439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.